APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Rapid Sterility Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Rapid Sterility Testing Market Analysis and Forecast 2026-2032

6 March 2026192 pages

Choose your research edition.

Industry ResearchPharmaceutical Rapid Sterility Testing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Rapid Sterility Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Rapid Sterility Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Rapid Sterility Testing Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Rapid Sterility Testing Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmaceutical Rapid Sterility Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Rapid Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Rapid Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Rapid Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Rapid Sterility Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Rapid Sterility Testing include Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings and Almac Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Rapid Sterility Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Rapid Sterility Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Rapid Sterility Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Rapid Sterility Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Rapid Sterility Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Rapid Sterility Testing revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Rapid Sterility Testing Segment by Company

Steris PLC

Charles River Laboratories International, Inc.

Thermo Fisher Scientific, Inc.

SGS S.A.

Sartorius AG

Sotera Health Company

Pacific Biolabs, Inc.

Laboratory Corporation of America Holdings

Almac Group

Pace Analytical Services, LLC

Pharmaceutical Rapid Sterility Testing Segment by Type

Bioburden Testing

Sterility Testing

Bacterial Endotoxin Testing

Pharmaceutical Rapid Sterility Testing Segment by Application

Pharmaceuticals

Medical Devices

Biopharmaceuticals

Pharmaceutical Rapid Sterility Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Rapid Sterility Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Rapid Sterility Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Rapid Sterility Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Rapid Sterility Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Rapid Sterility Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Rapid Sterility Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Rapid Sterility Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bioburden Testing Major Player Table 3. Sterility Testing Major Player Table 4. Bacterial Endotoxin Testing Major Player Table 5. Global Pharmaceutical Rapid Sterility Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceuticals Major Player Table 7. Medical Devices Major Player Table 8. Biopharmaceuticals Major Player Table 9. Pharmaceutical Rapid Sterility Testing Industry Trends Table 10. Pharmaceutical Rapid Sterility Testing Industry Drivers Table 11. Pharmaceutical Rapid Sterility Testing Industry Opportunities and Challenges Table 12. Pharmaceutical Rapid Sterility Testing Industry Restraints Table 13. Global Pharmaceutical Rapid Sterility Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Rapid Sterility Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Rapid Sterility Testing Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Rapid Sterility Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Rapid Sterility Testing Market Share by Region (2027-2032) Table 18. Global Pharmaceutical Rapid Sterility Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Players (2021-2026) Table 20. Global Pharmaceutical Rapid Sterility Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmaceutical Rapid Sterility Testing Key Players Headquarters & Area Served Table 22. Global Pharmaceutical Rapid Sterility Testing Players, Product Type & Application Table 23. Global Pharmaceutical Rapid Sterility Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmaceutical Rapid Sterility Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pharmaceutical Rapid Sterility Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Type (2027-2032) Table 31. Global Pharmaceutical Rapid Sterility Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Application (2021-2026) Table 35. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Application (2027-2032) Table 36. Steris PLC Company Information Table 37. Steris PLC Business Overview Table 38. Steris PLC Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Steris PLC Pharmaceutical Rapid Sterility Testing Product Portfolio Table 40. Steris PLC Recent Development Table 41. Charles River Laboratories International, Inc. Company Information Table 42. Charles River Laboratories International, Inc. Business Overview Table 43. Charles River Laboratories International, Inc. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Charles River Laboratories International, Inc. Pharmaceutical Rapid Sterility Testing Product Portfolio Table 45. Charles River Laboratories International, Inc. Recent Development Table 46. Thermo Fisher Scientific, Inc. Company Information Table 47. Thermo Fisher Scientific, Inc. Business Overview Table 48. Thermo Fisher Scientific, Inc. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Thermo Fisher Scientific, Inc. Pharmaceutical Rapid Sterility Testing Product Portfolio Table 50. Thermo Fisher Scientific, Inc. Recent Development Table 51. SGS S.A. Company Information Table 52. SGS S.A. Business Overview Table 53. SGS S.A. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. SGS S.A. Pharmaceutical Rapid Sterility Testing Product Portfolio Table 55. SGS S.A. Recent Development Table 56. Sartorius AG Company Information Table 57. Sartorius AG Business Overview Table 58. Sartorius AG Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Sartorius AG Pharmaceutical Rapid Sterility Testing Product Portfolio Table 60. Sartorius AG Recent Development Table 61. Sotera Health Company Company Information Table 62. Sotera Health Company Business Overview Table 63. Sotera Health Company Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sotera Health Company Pharmaceutical Rapid Sterility Testing Product Portfolio Table 65. Sotera Health Company Recent Development Table 66. Pacific Biolabs, Inc. Company Information Table 67. Pacific Biolabs, Inc. Business Overview Table 68. Pacific Biolabs, Inc. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Pacific Biolabs, Inc. Pharmaceutical Rapid Sterility Testing Product Portfolio Table 70. Pacific Biolabs, Inc. Recent Development Table 71. Laboratory Corporation of America Holdings Company Information Table 72. Laboratory Corporation of America Holdings Business Overview Table 73. Laboratory Corporation of America Holdings Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Laboratory Corporation of America Holdings Pharmaceutical Rapid Sterility Testing Product Portfolio Table 75. Laboratory Corporation of America Holdings Recent Development Table 76. Almac Group Company Information Table 77. Almac Group Business Overview Table 78. Almac Group Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Almac Group Pharmaceutical Rapid Sterility Testing Product Portfolio Table 80. Almac Group Recent Development Table 81. Pace Analytical Services, LLC Company Information Table 82. Pace Analytical Services, LLC Business Overview Table 83. Pace Analytical Services, LLC Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Pace Analytical Services, LLC Pharmaceutical Rapid Sterility Testing Product Portfolio Table 85. Pace Analytical Services, LLC Recent Development Table 86. North America Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Pharmaceutical Rapid Sterility Testing Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Pharmaceutical Rapid Sterility Testing Revenue by Country (US$ Million) & (2027-2032) Table 100. China Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 101. China Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 102. China Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 103. China Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Pharmaceutical Rapid Sterility Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Pharmaceutical Rapid Sterility Testing Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Pharmaceutical Rapid Sterility Testing Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Pharmaceutical Rapid Sterility Testing Image Figure 2. Global Pharmaceutical Rapid Sterility Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Rapid Sterility Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bioburden Testing Image Figure 5. Sterility Testing Image Figure 6. Bacterial Endotoxin Testing Image Figure 7. Global Pharmaceutical Rapid Sterility Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pharmaceutical Rapid Sterility Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceuticals Image Figure 10. Medical Devices Image Figure 11. Biopharmaceuticals Image Figure 12. Global Pharmaceutical Rapid Sterility Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Pharmaceutical Rapid Sterility Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Rapid Sterility Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Rapid Sterility Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pharmaceutical Rapid Sterility Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Pharmaceutical Rapid Sterility Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032) Figure 25. North America Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032) Figure 26. North America Pharmaceutical Rapid Sterility Testing Revenue Share by Country (2021-2032) Figure 27. United States Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032) Figure 32. Europe Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032) Figure 33. Europe Pharmaceutical Rapid Sterility Testing Revenue Share by Country (2021-2032) Figure 34. Germany Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032) Figure 44. China Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032) Figure 45. Asia Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032) Figure 47. Asia Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Rapid Sterility Testing Revenue Share by Region (2021-2032) Figure 49. Japan Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Pharmaceutical Rapid Sterility Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pharmaceutical Rapid Sterility Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
Applications
  • Pharmaceuticals
  • Medical Devices
  • Biopharmaceuticals
Companies covered
  • Steris PLC
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Sartorius AG
  • Sotera Health Company
  • Pacific Biolabs, Inc.
  • Laboratory Corporation of America Holdings
  • Almac Group
  • Pace Analytical Services, LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Rapid Sterility Testing Market by Type
  3. 1.2.1 Global Pharmaceutical Rapid Sterility Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bioburden Testing
  5. 1.2.3 Sterility Testing
  6. 1.2.4 Bacterial Endotoxin Testing
  7. 1.3 Pharmaceutical Rapid Sterility Testing Market by Application
  8. 1.3.1 Global Pharmaceutical Rapid Sterility Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceuticals
  10. 1.3.3 Medical Devices
  11. 1.3.4 Biopharmaceuticals
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pharmaceutical Rapid Sterility Testing Market Dynamics
  1. 2.1 Pharmaceutical Rapid Sterility Testing Industry Trends
  2. 2.2 Pharmaceutical Rapid Sterility Testing Industry Drivers
  3. 2.3 Pharmaceutical Rapid Sterility Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Rapid Sterility Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Rapid Sterility Testing Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Rapid Sterility Testing Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Rapid Sterility Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Rapid Sterility Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Rapid Sterility Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Rapid Sterility Testing Revenue by Players
  2. 4.1.1 Global Pharmaceutical Rapid Sterility Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Rapid Sterility Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Rapid Sterility Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Rapid Sterility Testing Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Rapid Sterility Testing Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Rapid Sterility Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Rapid Sterility Testing Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Rapid Sterility Testing Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Rapid Sterility Testing Market Size by Type
  1. 5.1 Global Pharmaceutical Rapid Sterility Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Rapid Sterility Testing Market Size by Application
  1. 6.1 Global Pharmaceutical Rapid Sterility Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Rapid Sterility Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Steris PLC
  2. 7.1.1 Steris PLC Company Information
  3. 7.1.2 Steris PLC Business Overview
  4. 7.1.3 Steris PLC Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Steris PLC Pharmaceutical Rapid Sterility Testing Product Portfolio
  6. 7.1.5 Steris PLC Recent Developments
  7. 7.2 Charles River Laboratories International, Inc.
  8. 7.2.1 Charles River Laboratories International, Inc. Company Information
  9. 7.2.2 Charles River Laboratories International, Inc. Business Overview
  10. 7.2.3 Charles River Laboratories International, Inc. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Charles River Laboratories International, Inc. Pharmaceutical Rapid Sterility Testing Product Portfolio
  12. 7.2.5 Charles River Laboratories International, Inc. Recent Developments
  13. 7.3 Thermo Fisher Scientific, Inc.
  14. 7.3.1 Thermo Fisher Scientific, Inc. Company Information
  15. 7.3.2 Thermo Fisher Scientific, Inc. Business Overview
  16. 7.3.3 Thermo Fisher Scientific, Inc. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific, Inc. Pharmaceutical Rapid Sterility Testing Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific, Inc. Recent Developments
  19. 7.4 SGS S.A.
  20. 7.4.1 SGS S.A. Company Information
  21. 7.4.2 SGS S.A. Business Overview
  22. 7.4.3 SGS S.A. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SGS S.A. Pharmaceutical Rapid Sterility Testing Product Portfolio
  24. 7.4.5 SGS S.A. Recent Developments
  25. 7.5 Sartorius AG
  26. 7.5.1 Sartorius AG Company Information
  27. 7.5.2 Sartorius AG Business Overview
  28. 7.5.3 Sartorius AG Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sartorius AG Pharmaceutical Rapid Sterility Testing Product Portfolio
  30. 7.5.5 Sartorius AG Recent Developments
  31. 7.6 Sotera Health Company
  32. 7.6.1 Sotera Health Company Company Information
  33. 7.6.2 Sotera Health Company Business Overview
  34. 7.6.3 Sotera Health Company Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sotera Health Company Pharmaceutical Rapid Sterility Testing Product Portfolio
  36. 7.6.5 Sotera Health Company Recent Developments
  37. 7.7 Pacific Biolabs, Inc.
  38. 7.7.1 Pacific Biolabs, Inc. Company Information
  39. 7.7.2 Pacific Biolabs, Inc. Business Overview
  40. 7.7.3 Pacific Biolabs, Inc. Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pacific Biolabs, Inc. Pharmaceutical Rapid Sterility Testing Product Portfolio
  42. 7.7.5 Pacific Biolabs, Inc. Recent Developments
  43. 7.8 Laboratory Corporation of America Holdings
  44. 7.8.1 Laboratory Corporation of America Holdings Company Information
  45. 7.8.2 Laboratory Corporation of America Holdings Business Overview
  46. 7.8.3 Laboratory Corporation of America Holdings Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Laboratory Corporation of America Holdings Pharmaceutical Rapid Sterility Testing Product Portfolio
  48. 7.8.5 Laboratory Corporation of America Holdings Recent Developments
  49. 7.9 Almac Group
  50. 7.9.1 Almac Group Company Information
  51. 7.9.2 Almac Group Business Overview
  52. 7.9.3 Almac Group Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Almac Group Pharmaceutical Rapid Sterility Testing Product Portfolio
  54. 7.9.5 Almac Group Recent Developments
  55. 7.10 Pace Analytical Services, LLC
  56. 7.10.1 Pace Analytical Services, LLC Company Information
  57. 7.10.2 Pace Analytical Services, LLC Business Overview
  58. 7.10.3 Pace Analytical Services, LLC Pharmaceutical Rapid Sterility Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pace Analytical Services, LLC Pharmaceutical Rapid Sterility Testing Product Portfolio
  60. 7.10.5 Pace Analytical Services, LLC Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Rapid Sterility Testing Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Rapid Sterility Testing Revenue by Country
  11. 8.6.1 North America Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Rapid Sterility Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Rapid Sterility Testing Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Rapid Sterility Testing Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Rapid Sterility Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Rapid Sterility Testing Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Rapid Sterility Testing Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Rapid Sterility Testing Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Rapid Sterility Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Rapid Sterility Testing Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Rapid Sterility Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Rapid Sterility Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Rapid Sterility Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst